Get Patient Support

For reimbursement support, contact R-Pharm US Access and Support in one of the following ways:

Call the Support Center at 1-855-991-7277, 8 AM to 8 PM ET, Monday through Friday

Fax the Support Center at 1-877-541-7813

Download and complete the forms as directed below:

R-Pharm US Access and Support enrollment form

Fill out this form with the help of your doctor or nurse to enroll in the R-Pharm US Access and Support program. This program offers helpful access and support resources. It can help review what benefits are covered under your plan for R-Pharm US medicines. It can also assist with the cost of your medicine if you have no active insurance.

R-Pharm US Access and Support patient authorization form

Fill out this form to allow the R-Pharm US Access and Support program to provide you with services and assistance. This form should be used only if you filled out an R-Pharm US Access and Support enrollment form but did not sign it.

The information provided is intended for use by individuals involved with reimbursement support.

The accurate completion of reimbursement or coverage-related documentation is the responsibility of the healthcare provider and patient. R-Pharm US and its agents make no guarantee regarding reimbursement for any service or item.

Indications and Important Safety Informationexpand

What is IXEMPRA® (ixabepilone)?

IXEMPRA is a prescription medicine used to treat locally advanced or metastatic breast cancer when certain other medicines have not worked or no longer work. IXEMPRA can be used alone or with another cancer medicine called Xeloda® (capecitabine).

Important Safety Information about IXEMPRA

Your healthcare provider should do blood tests to check how well your liver is working before you begin treatment with IXEMPRA and as needed during treatment. If blood tests show that you have liver problems, do not receive injections of IXEMPRA along with capecitabine. If you have liver problems, taking these medicines together could increase your chance of serious infection and death due to a very low white blood cell count (neutropenia).

You should not have your injection of IXEMPRA if you:

Before you receive treatment with IXEMPRA, tell your healthcare provider about all of your medical conditions, including any of the following:

You should also tell your healthcare provider if you:

While you are on treatment with IXEMPRA, you should avoid:

IXEMPRA may cause serious side effects. Tell your healthcare provider right away if you have any of the following while taking IXEMPRA:

The most common side effects of IXEMPRA, when used alone or with capecitabine, may include:

If you have any questions about your health or your medicines, talk with your healthcare provider.

Click here to see the Full Prescribing Information, including boxed WARNING regarding liver disease.